FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/10/046752 [Registered on: 25/10/2022] Trial Registered Prospectively
Last Modified On: 26/10/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Intravenous Versus Inhalational Anaesthetic agent on Oxygenation in Patients undergoing Thoracic Surgery  
Scientific Title of Study   Effect of Propofol Total Intravenous versus Sevoflurane Inhalational General Anaesthesia on Arterial Oxygenation During One-Lung Ventilation in Patients undergoing Open Thoracic Surgery: A Randomized Study  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Nadia Ahmad 
Designation  DNB Trainee 
Affiliation  Sir Gangaram Hospital, New Delhi 
Address  Sir Gangaram Hospital, Rajinder Nagar, New Delhi 110060

Central
DELHI
110060
India 
Phone  9538035310  
Fax    
Email  ahmad.nadia24@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jayashree Sood 
Designation  Head of Department 
Affiliation  Sir Gangaram Hospital, New Delhi 
Address  Rajinder Nagar, New Delhi 110060

Central
DELHI
110060
India 
Phone  9811294608  
Fax    
Email  drjayashreesood@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Nadia Ahmad 
Designation  DNB Trainee 
Affiliation  Sir Gangaram Hospital, New Delhi 
Address  Sir Gangaram Hospital, Rajinder Nagar, New Delhi 110060

Central
DELHI
110060
India 
Phone  9538035310  
Fax    
Email  ahmad.nadia24@gmail.com  
 
Source of Monetary or Material Support  
Sir Gangaram Hospital, New Delhi 
 
Primary Sponsor  
Name  Sir Gangaram Hospital 
Address  Sir Gangaram Hospital, Rajinder Nagar, New Delhi 110060 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Nadia Ahmad  Sir Gangaram Hospital  OT Complex 6th floor, SSRB Block, Sir Gangaram Hospital, Rajinder Nagar, New Delhi 110060
Central
DELHI 
9538035310

ahmad.nadia24@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics Commitee, SGRH  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J449||Chronic obstructive pulmonary disease, unspecified, (2) ICD-10 Condition: J869||Pyothorax without fistula,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Inhalational Agent  Sevoflurane Titrated to Maintain BIS between 40-60 
Comparator Agent  NA  NA 
Intervention  Total Intravenous Anaesthesia  Infusion of Propofol 2% to Maintain BIS Between 40-60 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1 Age of patient between 18-70 years.
2 All consenting patients to undergo open thoracic surgery.
3 American Society of Anaesthesiologist (ASA) physical status between 1-3.
4 Patients with unilateral lung pathology undergoing thoracic surgery.
 
 
ExclusionCriteria 
Details  1 Patients with bilateral pulmonary pathology.
2 Patients with baseline SpO2 < 90% at room air.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the Arterial Oxygenation PaO2 by serial ABG, in both the groups.  ABG to be taken at 5 predetermined time points, that is at 10 minutes of Two-lung ventilation after induction, then at 15,30,60 and 90 minutes after the start of One-lung ventilation. 
 
Secondary Outcome  
Outcome  TimePoints 
To compare Cardiac Output and Stroke Volume  10 minutes of Two-lung ventilation, then at 15,30,60 and 90 minutes after the start of One-lung ventilation. 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/10/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not at this time 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Intravenous propofol and various inhalational anaesthetic agents are the key components of modern general anaesthesia. Advances in thoracic surgery have been possible with the use of these modern anaesthetic agents.

One lung ventilation (OLV) is indicated for thoracic surgical procedures, for prevention of cross-contamination of the lungs and to control the distribution of ventilation.

However, during OLV, hypoxemia remains a major concern in the management of anaesthesia for thoracic surgery, due to pulmonary arteriovenous shunting of unsaturated pulmonary venous blood. Hypoxic pulmonary vasoconstriction acts as a defence mechanism against shunting. Therefore, in thoracic surgery, anaesthetics with minimal inhibitory effect on HPV and minimal haemodynamic changes are preferred. By limiting intrapulmonary shunting, the fall in arterial oxygen pressure can be attenuated, thus allowing better patient outcome.

This randomized study aims to evaluate the effect of two major anaesthetic agents, propofol and sevoflurane on arterial oxygenation during one lung ventilation in adults undergoing elective right sided open thoracic surgery.

 
Close